Home › Funds › Integral Health Asset Management, LLC › MDGL
Integral Health Asset Management, LLC position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
Integral Health Asset Management, LLC reported holding 25,000 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$12.6M, representing 0.82% of its reported portfolio and ranking #39 among its reported holdings. Integral Health Asset Management, LLC has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Integral Health Asset Management, LLC's MDGL position evolved
Integral Health Asset Management, LLC first disclosed a stake in MDGL in Q1 2026 at 25,000 shares (US$13.1M). The position peaked in Q2 2026 at 25,000 shares, worth US$13.4M. Across 3 filings, Integral Health Asset Management, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 25,000 shares valued at US$12.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 25.00K | $13.09M | New |
| Q2 2026 | 25.00K | $13.42M | Hold |
| Q3 2026 | 25.00K | $12.60M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), Janus Henderson Group (US$1.05B), Jupiter Topco LLC (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $923.93M · Q3 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 337.04K sh · $169.85M · Q3 2026
- RTW INVESTMENTS, LP 312.82K sh · $157.65M · Q3 2026
- Rock Springs Capital Management LP 177.25K sh · $89.33M · Q3 2026
- Hood River Capital Management LLC 170.68K sh · $86.02M · Q3 2026
More on Integral Health Asset Management, LLC
FAQ
How long has Integral Health Asset Management, LLC held MDGL?
Integral Health Asset Management, LLC has disclosed MDGL holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Integral Health Asset Management, LLC's current position in MDGL?
As of Q3 2026, Integral Health Asset Management, LLC holds 25.00K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $12.60M, representing 0.82% of its reported portfolio and ranking #39.
Has Integral Health Asset Management, LLC been buying or selling MDGL?
In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in MDGL. The position peaked in Q2 2026 at 25.00K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Janus Henderson Group, Jupiter Topco LLC, among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.